Form 8-K - Current report:
SEC Accession No. 0001367644-23-000004
Filing Date
2023-01-09
Accepted
2023-01-09 06:55:28
Documents
20
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20230109.htm   iXBRL 8-K 39369
2 EX-99.1 final_jan9ebsorganizatio.htm EX-99.1 20152
6 GRAPHIC final_jan9ebsorganizatio001.jpg GRAPHIC 235213
7 GRAPHIC final_jan9ebsorganizatio002.jpg GRAPHIC 189457
8 GRAPHIC final_jan9ebsorganizatio003.jpg GRAPHIC 238790
9 GRAPHIC final_jan9ebsorganizatio004.jpg GRAPHIC 170947
10 GRAPHIC final_jan9ebsorganizatio005.jpg GRAPHIC 196721
11 GRAPHIC final_jan9ebsorganizatio006.jpg GRAPHIC 291226
12 GRAPHIC final_jan9ebsorganizatio007.jpg GRAPHIC 55074
  Complete submission text file 0001367644-23-000004.txt   2108765

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230109.xsd EX-101.SCH 1965
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230109_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230109_pre.xml EX-101.PRE 13100
14 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230109_htm.xml XML 11453
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 23516478
SIC: 2834 Pharmaceutical Preparations